New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
10:00 EDTABC, MCK, CTRX, ESRX, CAH, WAG, CVSLeerink's healthcare tech analyst holds an analyst/industry conference call
Healthcare Technology Analyst Larsen, along with MEDACorp Specialists Brian Anderson and Mary Beth Mulligan, discuss the quality of service and performance provided by each PBM (Pharmacy Benefit Manager) on an Analyst/Industry conference call. Relevant companies ABC, CAH, CTRX, CVS, ESRX, MCK and WAG may be included on the Analyst/Industry conference call to be held on March 31 at 11 am.
News For ABC;CAH;CTRX;CVS;ESRX;MCK;WAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 15, 2015
12:07 EDTMCKThird Point reports new stakes in Yum! Brands, FedEx, McKesson
10:34 EDTCTRXOptions with increasing implied volatility
Subscribe for More Information
10:29 EDTCAHAmerican Urological Association to hold an annual meeting
Subscribe for More Information
May 14, 2015
11:08 EDTESRXExpress Scripts management to meet with Maxim
Meeting to be held in St. Louis, MO on May 21 hosted by Maxim.
11:06 EDTCTRXOptions with increasing implied volatility
Subscribe for More Information
May 13, 2015
11:47 EDTCVSCVS Health says to pay $22M in settlement with DEA, USAO
CVS Health said in a regulatory filing that it has entered into an agreement with the U.S. Attorney’s Office for the Middle District of Florida and the U.S. Drug Enforcement Administration to resolve previously-disclosed allegations relating to the dispensing of certain controlled substances in Florida. CVS Health agreed to pay $22M and the settlement resolves all civil matters between the Company and the DEA in the state of Florida. This payment amount has been fully accrued for in prior fiscal periods.
11:22 EDTCTRXOptions with increasing implied volatility
Subscribe for More Information
10:07 EDTMCKHigh option volume stocks
Subscribe for More Information
09:56 EDTMCKEquity options with increasing volume
Subscribe for More Information
09:12 EDTABCAmerisourceBergen price target raised to $135 from $104 at Argus
Subscribe for More Information
08:54 EDTMCKMcKesson price target raised to $252 from $234 at Cowen
Subscribe for More Information
07:55 EDTMCKMcKesson Q4 results 'outstanding,' says Baird
Subscribe for More Information
07:31 EDTMCKHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.
May 12, 2015
16:20 EDTMCKMcKesson authorizes $500M repurchase program
Subscribe for More Information
16:18 EDTMCKMcKesson sees FY16 EPS $12.20-$12.70, consensus $12.57
Sees FY16 distribution solutions revenue growth in mid-single digits. Sees North America pharmaceutical distribution and services delivering high-single digit revenue growth. Sees international pharmaceutical and distribution services revenues flat year-over-year on constant currency basis. Sees medical-surgical distribution and services delivering mid-single digit revenue growth. Sees branded drug price trends in U.S. similar to FY15. Sees price trends on generic drugs outside an exclusivity period, in the U.S. market, slightly below FY15. Sees profit contribution from launch of new oral generic pharmaceuticals in the U.S. market decreasing. Sees technology solutions revenue declining mid-single digits driven by revenue decline in our hospital software business and pending sale of a business line. Guidance assumes adjusted tax rate 31.5%. Sees cash flow from operations $3B.
16:14 EDTMCKMcKesson reports Q4 adjusted adjusted EPS $2.94, consensus $2.75
Subscribe for More Information
15:00 EDTMCKNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include McKesson (MCK), consensus $2.75... Zillow (Z), consensus (12c)... GoDaddy (GDDY), consensus 35c... RSP Permian (RSPP), consensus 17c... Parsley Energy (PE), consensus 0c... Vivint Solar (VSLR), consensus (38c)... New Relic (NEWR), consensus (25c)... Hortonworks (HDP), consensus (86c)... SunOpta (STKL), consensus 7c... OPOWER (OPWR), consensus (16c)... JP Energy Partners (JPEP), consensus (4c)... TubeMogul (TUBE), consensus (18c)... Ducommun (DCO), consensus 30c.
10:28 EDTCTRXOptions with increasing implied volatility: YELP HUM LULU CTRX
Subscribe for More Information
07:56 EDTMCKMcKesson has a conference call hosted by JPMorgan
JPMorgan Analyst Gill will host a conference call with CEO John Hammergren on May 13 at 10:30 am.
May 11, 2015
07:40 EDTCTRX, CVS, ESRXFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertex’s Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasn’t announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use